HONG KONG: There are 70 coronavirus vaccines in development globally, with three candidates already being tested in human trials, according to the World Health Organisation (WHO), as drugmakers race to find a cure for the deadly pathogen.
The furthest along in the clinical process is an experimental vaccine developed by Hong Kong-listed CanSino Biologics Inc and the Beijing Institute of Biotechnology, which is in phase 2.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
